ethionamide and morphazinamide

ethionamide has been researched along with morphazinamide* in 1 studies

Other Studies

1 other study(ies) available for ethionamide and morphazinamide

ArticleYear
Ion interaction reagent reversed-phase high-performance liquid chromatography determination of anti-tuberculosis drugs and metabolites in biological fluids.
    Journal of chromatography. B, Biomedical sciences and applications, 2001, Apr-25, Volume: 754, Issue:2

    New methods of ion interaction reagent (IIR) RP-HPLC are presented for the determination of anti-tuberculosis drugs and their metabolites, singly or in multi-component mixtures, in biological fluids. The following analytes are considered: isoniazid, ethionamide, pyrazinamide, morphazinamide, p-aminosalicylic acid, nicotinic and isonicotinic acids. Aqueous solutions of three different ion interaction reagents are alternatively or comparatively used as the mobile phases, namely: (A) 5.00 mM octylamine at pH 3.00 for o-phosphoric acid, (B) 5.00 mM octylamine at pH 8.00 for o-phosphoric acid, and (C) 5.00 mM 1,6 diaminohexane at pH 6.00 for o-phosphoric acid. The response linearity between peak area and analyte concentration is verified for all the analytes in the concentration range within the determination limits and 2.00 mg/l. Detection limits are always lower than 82 microg/l for standard solutions; in the analysis of samples of rat serum, rat plasma and human serum, the matrix effect is negligible, the detection limits are always lower than 94 microg/l and the average recovery yield is always greater than 96%.

    Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Calibration; Chromatography, High Pressure Liquid; Ethionamide; Humans; Isoniazid; Isonicotinic Acids; Niacin; Pyrazinamide; Pyrazines; Quality Control; Rats

2001